2000
DOI: 10.1086/315483
|View full text |Cite
|
Sign up to set email alerts
|

Central Nervous System Activation of the Indoleamine‐2,3‐Dioxygenase Pathway in Human T Cell Lymphotropic Virus Type I–Associated Myelopathy/Tropical Spastic Paraparesis

Abstract: Human T cell lymphotropic virus type I (HTLV-I) is associated with a chronic neurologic disease called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The potential mechanisms of HAM/TSP pathogenesis were assessed by examination of 2 pathways initiated by interferon-gamma, a predominant cytokine in HAM/TSP. Jamaican HAM/TSP patients (n=17) were compared with patients with other neurologic diseases (ONDs; n=13) with respect to cerebrospinal fluid levels of the following: neopterin; nitrite … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The first and regulatory enzyme of the KP, indoleamine 2,3‐dioxygenase (IDO) (EC 1.13.11.17), has been shown to be increased in several brain diseases such as AIDS dementia complex (Sardar and Reynolds, 1995; Smith et al, 2001; Burudi et al, 2002), viral brain infection (Heyes et al, 1992; Maloney et al, 2000), brain abscesses (Schroten et al, 2001), cerebral malaria (Hansen et al, 2000), Alzheimer's disease (Guillemin et al, 2003a), epilepsy (Nakano et al, 1992), and glioblastoma (Uyttenhove et al, 2003). IDO can be strongly induced by inflammatory cytokines such as interferon‐γ (IFN‐γ), and to a lesser extent by TNF‐α and IFN‐α (Heyes et al, 1997a; Pemberton et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…The first and regulatory enzyme of the KP, indoleamine 2,3‐dioxygenase (IDO) (EC 1.13.11.17), has been shown to be increased in several brain diseases such as AIDS dementia complex (Sardar and Reynolds, 1995; Smith et al, 2001; Burudi et al, 2002), viral brain infection (Heyes et al, 1992; Maloney et al, 2000), brain abscesses (Schroten et al, 2001), cerebral malaria (Hansen et al, 2000), Alzheimer's disease (Guillemin et al, 2003a), epilepsy (Nakano et al, 1992), and glioblastoma (Uyttenhove et al, 2003). IDO can be strongly induced by inflammatory cytokines such as interferon‐γ (IFN‐γ), and to a lesser extent by TNF‐α and IFN‐α (Heyes et al, 1997a; Pemberton et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…In adult neurology, CSF neopterin is a useful marker of CNS infection and inflammation, 6 particularly in assessing human immunodeficiency virus encephalopathy and its treatment 7,8 . CSF neopterin is also elevated in acute infection (bacterial meningitis and viral encephalitis), 6 chronic infection (subacute sclerosing panencephalitis, human T‐cell lymphotropic virus type 1), 9,10 and chronic inflammatory disorders (sarcoidosis and neuro‐Behçets) 2,11 . CSF neopterin also has some uses in demyelinating disorders such as multiple sclerosis, although its sensitivity is very dependent on the activity of demyelination at the time of testing 12,13 …”
mentioning
confidence: 99%